Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8035913rdf:typepubmed:Citationlld:pubmed
pubmed-article:8035913lifeskim:mentionsumls-concept:C0015859lld:lifeskim
pubmed-article:8035913lifeskim:mentionsumls-concept:C0042963lld:lifeskim
pubmed-article:8035913lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:8035913lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:8035913lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8035913lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:8035913lifeskim:mentionsumls-concept:C0247133lld:lifeskim
pubmed-article:8035913pubmed:issue2lld:pubmed
pubmed-article:8035913pubmed:dateCreated1994-8-12lld:pubmed
pubmed-article:8035913pubmed:abstractTextThese studies have examined the effects of the selective neurokinin1 (NK1) receptor antagonist CP-99,994 on the retching and vomiting response to apomorphine. CP-99,994 (1-3 mg/kg i.p.) attenuated retching and vomiting induced by apomorphine (0.25 mg/kg s.c.) with complete inhibition of retching and vomiting at the 3 mg/kg dose. In contrast CP-100,263 (3 mg/kg i.p.), the enantiomer of CP-99,994 with 1000-fold lower affinity for the NK1 receptor, was without effect.lld:pubmed
pubmed-article:8035913pubmed:languageenglld:pubmed
pubmed-article:8035913pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035913pubmed:citationSubsetIMlld:pubmed
pubmed-article:8035913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035913pubmed:statusMEDLINElld:pubmed
pubmed-article:8035913pubmed:monthFeblld:pubmed
pubmed-article:8035913pubmed:issn0028-3908lld:pubmed
pubmed-article:8035913pubmed:authorpubmed-author:HillR GRGlld:pubmed
pubmed-article:8035913pubmed:authorpubmed-author:HargreavesR...lld:pubmed
pubmed-article:8035913pubmed:authorpubmed-author:RycroftWWlld:pubmed
pubmed-article:8035913pubmed:authorpubmed-author:TattersallF...lld:pubmed
pubmed-article:8035913pubmed:issnTypePrintlld:pubmed
pubmed-article:8035913pubmed:volume33lld:pubmed
pubmed-article:8035913pubmed:ownerNLMlld:pubmed
pubmed-article:8035913pubmed:authorsCompleteYlld:pubmed
pubmed-article:8035913pubmed:pagination259-60lld:pubmed
pubmed-article:8035913pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:meshHeadingpubmed-meshheading:8035913-...lld:pubmed
pubmed-article:8035913pubmed:year1994lld:pubmed
pubmed-article:8035913pubmed:articleTitleEnantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994.lld:pubmed
pubmed-article:8035913pubmed:affiliationMerck, Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, U.K.lld:pubmed
pubmed-article:8035913pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8035913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8035913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8035913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8035913lld:pubmed